The old cancer playbook — cut, poison, burn — was never designed for long-term remission. It was designed to attack the tumor, not to strengthen the immune system that deletes cancer 10,000 times a day when healthy.
In this episode of Outsmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, breaks down why standard surgery, chemo, and radiation often lead to relapse and resistance — and how immune-centric precision oncology flips the script. Instead of carpet-bombing the body, precision care uses deep multi-omics testing, microdosed genetically targeted chemotherapy, and direct-to-tumor delivery to destroy cancer while empowering the immune system.
You’ll learn how dendritic cells act as detectives, how natural killer cells act as snipers, and how DAMP signaling “lights up” the tumor so the immune system can find it. From image-guided cryoablation to catheter-based CIPI therapy, this episode shows how precision care eliminates guesswork, reduces toxicity, and builds long-term immune memory — the real path to durable remission.
🎯 What You’ll Learn in This Episode:
• Why relapse happens even when treatment “works at first”
• How maximum-dose chemo weakens immunity and increases resistance
• Why only 0.7% of IV chemo reaches the tumor
• How direct-to-tumor delivery increases that to 98–100%
• The role of NK cells, dendritic cells & DAMP signaling in immune targeting
• How DNA, RNA & spatial biology guide treatment with thousands of data points
📍 Envita Medical Centers – Scottsdale, AZ
🌐 Learn more: www.envita.com
📞 Speak to a care coordinator: 866-830-4576
Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.
You can read the full peer-reviewed study at:
https://www.scirp.org/journal/paperinformation?paperid=132493
